연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2891. The longitudinal effects of chronotype on chemotherapy-induced nausea and vomiting in patients with breast cancer receiving neoadjuvant chemotherapy
Sanghyup Jung 1, Kyung-Lak Son 2, Saim Jung 1, Jung Yoon Moon 1, Gyu Han Oh 3, Chan-Woo Yeom 4, Kwang-Min Lee 5, Won-Hyoung Kim 6, Dooyoung Jung 7, Tae-Yong Kim 8, Seock-Ah Im 9, Kyung-Hun Lee 8, David Spiegel 10, Bong-Jin Hahm 11
J Psychosom Res. 2022 Jun;157:110804.
Link
2890. Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
Javier Cortés 1, Sung-Bae Kim 1, Wei-Pang Chung 1, Seock-Ah Im 1, Yeon Hee Park 1, Roberto Hegg 1, Min Hwan Kim 1, Ling-Ming Tseng 1, Vanessa Petry 1, Chi-Feng Chung 1, Hiroji Iwata 1, Erika Hamilton 1, Giuseppe Curigliano 1, Binghe Xu 1, Chiun-Sheng Huang 1, Jee Hyun Kim 1, Joanne W Y Chiu 1, Jose Luiz Pedrini 1, Caleb Lee 1, Yali Liu 1, Jillian Cathcart 1, Emarjola Bako 1, Sunil Verma 1, Sara A Hurvitz 1; DESTINY-Breast03 Trial Investigators
N Engl J Med. 2022 Mar 24;386(12):1143-1154.
Link
2889. Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer
Kyung-Lak Son 1, Dooyoung Jung 2, Kwang-Min Lee 3, Chan-Woo Yeom 4, Gyu Han Oh 5, Tae-Yong Kim 6 7, Seock-Ah Im 6 7 8, Kyung-Hun Lee 6 7, David Spiegel 9, Bong-Jin Hahm 10
J Korean Med Sci. 2022 Feb 7;37(5):e34.
Link
2888. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
Peter Schmid 1, Javier Cortes 1, Rebecca Dent 1, Lajos Pusztai 1, Heather McArthur 1, Sherko Kümmel 1, Jonas Bergh 1, Carsten Denkert 1, Yeon Hee Park 1, Rina Hui 1, Nadia Harbeck 1, Masato Takahashi 1, Michael Untch 1, Peter A Fasching 1, Fatima Cardoso 1, Jay Andersen 1, Debra Patt 1, Michael Danso 1, Marta Ferreira 1, Marie-Ange Mouret-Reynier 1, Seock-Ah Im 1, Jin-Hee Ahn 1, Maria Gion 1, Sally Baron-Hay 1, Jean-François Boileau 1, Yu Ding 1, Konstantinos Tryfonidis 1, Gursel Aktan 1, Vassil
N Engl J Med. 2022 Feb 10;386(6):556-567.
Link
2887. Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study
Ian E Krop 1, Seock-Ah Im 2, Carlos Barrios 3, Hervé Bonnefoi 4, Julie Gralow 5, Masakazu Toi 6, Paul A Ellis 7, Luca Gianni 8, Sandra M Swain 9, Young-Hyuck Im 10, Michelino De Laurentiis 11, Zbigniew Nowecki 12, Chiun-Sheng Huang 13, Louis Fehrenbacher 14, Yoshinori Ito 15, Jigna Shah 16, Thomas Boulet 17, Haiying Liu 16, Harrison Macharia 17, Peter Trask 16, Chunyan Song 16, Eric P Winer 1, Nadia Harbeck 18
Affiliations expand
J Clin Oncol. 2022 Feb 10;40(5):438-448.
Link
2886. Accuracy of preoperative clinical staging for locally advanced gastric cancer in KLASS-02 randomized clinical trial
Kim DJ, Hyung WJ, Park YK, Lee HJ, An JY, Kim HI, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Kim JJ, Park DJ, Ryu KW, Kim YW, Kim JW, Lee JH, Yang HK, Han SU, Kim W
Front Surg. 2022 Sep 23;9:1001245.
Link
2885. Retrospective Cohort Study on the Longterm Oncologic Outcomes of Sentinel Lymph Node Mapping Methods (Dye-Only Versus Dye and Radioisotope Mapping) in Early Breast Cancer: A Propensity Score-Matched Analysis
Lim C, Kang E, Jung JG, Cheun JH, Kim HK, Lee HB, Moon HG, Han W.
Cancer Res Treat. 2022 Sep 26. doi: 10.4143/crt.2022.871. Online ahead of print.
Link
2884. Musculoskeletal Pain and the Prevalence of Rheumatoid Arthritis in Breast Cancer Patients During Cancer Treatment: A Retrospective Study
Ju Yeon Kim, Min Jung Kim, Eun Bong Lee, Tae-Yong Kim, Kyung-Hun Lee, Seock-Ah Im, Jin Kyun Park
Journal of breast cancer 2022. 25(5):404-414.
Link
2883. Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial
Ahn HK, Sim SH, Suh KJ, Kim MH, Jeong JH, Kim JY, Lee DW, Ahn JH, Chae H, Lee KH, Kim JH, Lee KS, Sohn JH, Choi YL, Im SA, Jung KH, Park YH
JAMA oncology 2022. 8(9):1271-1277.
Link
2882. Do posttraumatic stress symptoms predict trajectories of sleep disturbance and fatigue in patients with breast cancer? A parallel-process latent growth model
Eun‐Jung Shim, Donghee Jeong, Dooyoung Jung, Tae‐Yong Kim, Kyung‐Hun Lee, Seock‐Ah Im, Bong‐Jin Hahm
Psychooncology 2022. 31(8):1286-1293
Link